Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) EBT Margin (2019 - 2025)

Eton Pharmaceuticals' EBT Margin history spans 7 years, with the latest figure at 6.64% for Q4 2025.

  • On a quarterly basis, EBT Margin rose 1103.0% to 6.64% in Q4 2025 year-over-year; TTM through Dec 2025 was 7.07%, a 269.0% increase, with the full-year FY2025 number at 5.7%, up 406.0% from a year prior.
  • EBT Margin hit 6.64% in Q4 2025 for Eton Pharmaceuticals, up from 8.7% in the prior quarter.
  • Over the last five years, EBT Margin for ETON hit a ceiling of 43.0% in Q1 2021 and a floor of 786.32% in Q3 2021.
  • Historically, EBT Margin has averaged 66.05% across 5 years, with a median of 9.44% in 2024.
  • The widest YoY moves for EBT Margin: up 2358427bps in 2021, down -25621628bps in 2021.
  • Tracing ETON's EBT Margin over 5 years: stood at 17.05% in 2021, then plummeted by -37bps to 10.73% in 2022, then crashed by -163bps to 6.74% in 2023, then soared by 35bps to 4.39% in 2024, then skyrocketed by 251bps to 6.64% in 2025.
  • Business Quant data shows EBT Margin for ETON at 6.64% in Q4 2025, 8.7% in Q3 2025, and 13.31% in Q2 2025.